Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Pharmaceutics|December 7, 2023
Predicting Long-Term Stability of an Oral Delivered Antibody Drug Product with Accelerated Stability Assessment Program ModelingLulu Dai, Jeff Davis, Karthik Nagapudi, et al.Analytical Chemistry|December 29, 2023
Probing the Protein-Excipient Interaction in the Orally Delivered Protein by Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry and Molecular DynamicsXiao Pan, Sunidhi Lenka, Jeff Davis, et al.Journal of Pharmaceutical Sciences|January 15, 2019
Cyclodextrin Reduces Intravenous Toxicity of a Model CompoundPriscilla Mantik, Minli Xie, Harvey Wong, et al.Proceedings of the National Academy of Sciences of the United States of America|May 28, 2025
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signalingNaruhisa Ota, Christopher W Davies, Jing Kang, et al.Bioorganic & Medicinal Chemistry Letters|August 24, 2017
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis modelJun Liang, Anne Van Abbema, Mercedesz Balazs, et al.European Journal of Medicinal Chemistry|July 23, 2013
Lead identification of novel and selective TYK2 inhibitorsJun Liang, Vickie Tsui, Anne Van Abbema, et al.Journal of Medicinal Chemistry|May 15, 2013
Lead optimization of a 4-aminopyridine benzamide scaffold to identify potent, selective, and orally bioavailable TYK2 inhibitorsJun Liang, Anne van Abbema, Mercedesz Balazs, et al.Pageof 1